share_log

Enliven Therapeutics(ELVN.US) Director Sells US$30,149.67 in Common Stock

moomoo News ·  May 20 20:29

$Enliven Therapeutics (ELVN.US)$ Director Heyman Richard A. sold 1,270 shares of common stock on May 16, 2024 at an average price of $23.7399 for a total value of $30,149.67.

1716251355571470284.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment